Victory Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40M Sell
413,715
-13,157
-3% -$1.35M 0.03% 623
2025
Q4
$45.3M Sell
426,872
-37,177
-8% -$4.31M 0.03% 582
2025
Q3
$58.9M Sell
464,049
-31,127
-6% -$3.71M 0.03% 490
2025
Q2
$60.7M Sell
495,176
-75,130
-13% -$8.58M 0.04% 471
2025
Q1
$57.8M Buy
570,306
+42,245
+8% +$4.12M 0.06% 402
2024
Q4
$48.8M Sell
528,061
-43,958
-8% -$4.32M 0.05% 471
2024
Q3
$55.3M Sell
572,019
-27,369
-5% -$2.46M 0.05% 429
2024
Q2
$51.4M Sell
599,388
-287,244
-32% -$24.1M 0.05% 434
2024
Q1
$73.2M Sell
886,632
-37,256
-4% -$2.73M 0.07% 338
2023
Q4
$61.6M Sell
923,888
-45,950
-5% -$2.98M 0.06% 368
2023
Q3
$65.1M Sell
969,838
-113,672
-10% -$7.82M 0.07% 339
2023
Q2
$73.4M Buy
1,083,510
+8,606
+0.8% +$539K 0.08% 309
2023
Q1
$58.2M Sell
1,074,904
-1,916
-0.2% -$112K 0.07% 389
2022
Q4
$64.4M Sell
1,076,820
-1,210,764
-53% -$65.8M 0.07% 360
2022
Q3
$103M Sell
2,287,584
-411,082
-15% -$20.6M 0.12% 214
2022
Q2
$120M Buy
2,698,666
+771,229
+40% +$39.6M 0.14% 176
2022
Q1
$106M Sell
1,927,437
-9,970
-0.5% -$521K 0.11% 248
2021
Q4
$101M Sell
1,937,407
-194,993
-9% -$10.1M 0.09% 282
2021
Q3
$127M Buy
2,132,400
+7,389
+0.3% +$465K 0.12% 193
2021
Q2
$132M Sell
2,125,011
-501,777
-19% -$33.4M 0.13% 192
2021
Q1
$171M Sell
2,626,788
-32,380
-1% -$2.11M 0.18% 132
2020
Q4
$175M Sell
2,659,168
-85,368
-3% -$5.02M 0.19% 114
2020
Q3
$142M Sell
2,744,536
-118,781
-4% -$6.1M 0.18% 135
2020
Q2
$141M Buy
2,863,317
+81,936
+3% +$4.42M 0.19% 126
2020
Q1
$142M Buy
2,781,381
+1,689,332
+155% +$97.4M 0.12% 242
2019
Q4
$60.2M Buy
1,092,049
+674,117
+161% +$36.6M 0.07% 404
2019
Q3
$21M Buy
417,932
+142,864
+52% +$7.18M 0.03% 775
2019
Q2
$13.9M Sell
275,068
-128,814
-32% -$6.25M 0.03% 713
2019
Q1
$18.8M Sell
403,882
-919,666
-69% -$46.6M 0.04% 586
2018
Q4
$65M Sell
1,323,548
-157,314
-11% -$8.95M 0.16% 165
2018
Q3
$91.8M Sell
1,480,862
-680,956
-31% -$41.4M 0.19% 129
2018
Q2
$116M Sell
2,161,818
-80,386
-4% -$4.02M 0.25% 86
2018
Q1
$102M Buy
2,242,204
+4,251
+0.2% +$182K 0.22% 106
2017
Q4
$88M Buy
2,237,953
+173,271
+8% +$6.59M 0.19% 149
2017
Q3
$76.1M Sell
2,064,682
-40,471
-2% -$1.44M 0.17% 171
2017
Q2
$81.1M Sell
2,105,153
-199,240
-9% -$7.3M 0.19% 142
2017
Q1
$78.5M Sell
2,304,393
-165,749
-7% -$5.44M 0.19% 158
2016
Q4
$81M Sell
2,470,142
-1,633,900
-40% -$53M 0.2% 137
2016
Q3
$132M Sell
4,104,042
-185,995
-4% -$6.03M 0.37% 29
2016
Q2
$132M Sell
4,290,037
-330,055
-7% -$10.3M 0.53% 8
2016
Q1
$138M Buy
4,620,092
+95,714
+2% +$2.64M 0.57% 8
2015
Q4
$125M Buy
4,524,378
+56,897
+1% +$1.62M 0.52% 25
2015
Q3
$136M Buy
4,467,481
+58,924
+1% +$2.05M 0.56% 20
2015
Q2
$162M Sell
4,408,557
-102,411
-2% -$3.65M 0.6% 16
2015
Q1
$159M Sell
4,510,968
-7,153
-0.2% -$245K 0.57% 24
2014
Q4
$138M Buy
+4,518,121
New +$141M 0.51% 29

Other funds holding EHC

Victory Capital Management's EHC Position: Q1 2026 in Review

Victory Capital Management reduced its Encompass Health (EHC) stake by 3.1% in Q1 2026, selling an estimated $1.35M and leaving 413,715 shares worth $40M. The position accounts for 0.03% of the portfolio, ranked #623.

Victory Capital Management first reported a position in EHC in Q4 2014 and has held it in 46 quarters since. The position peaked at $175M in Q4 2020. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Victory Capital Management held 413,715 shares of Encompass Health worth $40M as of Q1 2026.
  • Victory Capital Management sold 13,157 Encompass Health shares in Q1 2026, an estimated $1.35M.
  • Encompass Health made up 0.03% of Victory Capital Management's portfolio in Q1 2026, its #623 holding.
  • Victory Capital Management first reported a position in Encompass Health in Q4 2014 and has held it in 46 quarters since.
  • Victory Capital Management's Encompass Health position peaked at $175M in Q4 2020.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.